3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
22
Pancreatic Neoplasms
16
Neoplasm Metastasis
9
Rectal Neoplasms
5
Neuroblastoma
5
Neoplasms
5
Colonic Neoplasms
5
Stomach Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Lung Neoplasms
4
Sarcoma, Ewing
3
Cholangiocarcinoma
3
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Medulloblastoma
2
Hepatoblastoma
2
Glioma
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Bone Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Solid Cancer
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Locally Advanced Pancreatic Cancer
×
Irinotecan
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled